#chipseq

[jobrxiv]

Postdoctoral Fellow University of Texas MD Anderson Cancer Center The Ishak laboratory at MD Anderson Cancer Center is seeking candidates for a Postdoctoral Fellowship. See the full job description on jobRxiv: https://jobrxiv.org/job/university-of-texas-md-anderson-cancer-center-27778-postdoctoral-fellow/?feed_id=59126 #ScienceJobs #hiring #research #ViralMimicry, #DNArepetitiveElements, #epigenetics, #cancer, #premalignancy, #p53, #OvarianCancer, #MolecularCarcinogenesis, #MolecularBiology, #CRISPR, #ChIPseq, #immunology Houston, Texas #UnitedStatesUS #PostdoctoralFellow

[queenofthebench]

Epic Win: Breaking new ground

My biggest success of grad school has been doing chromatin immunoprecipitation followed by high throughput sequencing for the transcription factor I study in a tissue type where it has been completely uncharacterized. People have tried to do similar experiments before and have been unsuccessful. Through this experiment I have brought new techniques to the lab and been forced to step outside of my comfort zone. I have also learned how to code and do bioinformatics analysis which is something that I have always wanted to learn and understand.

-Anonymous

[biodiscovery-group]

WORKSHOP in ChIP Sequencing | Live session | Only in ₹ 280 & US $ 7 🤳🤳Video of the session will be recorded and shared with the registered participants. Register from here https://www.townscript.com/e/chip-sequencing-course All upcoming https://www.bdglifesciences.com/courses #envisionwithbdg #itsdifferentbybiodiscovery #bdglifesciences #bioinformatics #biotechnology #bioinformaticscompany #10yearsofexcellence #biodiscoverygroup #onlineteaching #onlinelearning #NGSDataAnalysis #nextgenerationsequencing #metagenomics #metagenome #functionalgenomics #genomeanalysis #CHIPseq https://www.instagram.com/p/CKItp5LDdfX/?igshid=q0s45k6s08v

[sachwlang]

After more than a decade, ChIP-seq may be quantitative after all — ScienceDaily For more than a decade, scientists studying epigenetics have used a powerful method called ChIP-seq to map changes in proteins and other critical regulatory factors across the genome.

[itsnot365papers]

Sampling the proteome by emerging single-molecule and mass-spectrometry methods

MacCoss, Alfaro, Wanunu, Faivre, Slavov

arxiv.org, 2022

Summary points:

comparing lc ms to methods like chipseq, illumina sequencing, nanopore (?) etc to evaluate potential advancement sin technology and best strategy for proteomics

needs to have high molecule counting capabilities to account for big dynamic range (this sections doesn't make direct comparison to small molecule methods)

ion counting- not all ions get measured, not all measured ions map to peptides,

ion counting issues also relate to dynamic range problem- more abundant proteins take up more of the ions and the odds of counting a low abundant peptide ion is low

scalability- single molecule methods work for those because they require fewer reads than a protein method would, so far it is hard to scale up relative to LC MS

scalability in some cases also has to do with scale of microscopy, which further makes large scale single molecule methods very challenging/ not high throughput

LCMS is limited still by enzymes used to digest samples, requirement of peptides being in gas phase, ionization efficiency

other things to improve in LC MS- fractionation, overcoming sample bias, counting multiple molecules at once, considering the profitability vs importance of technology development (LCMS is less profitable but potentially more powerful)

questions:

are there ways to streamline fractionation processes to make this a less labor intensive way of expanding proteome coverage?

how is ionization efficiency measured? or increased?

why is such a small fraction (1/50,pg 10) of the ion beam being used ? how does this number change with various setting on the mass spec and experimental set up? (& ESI setup)

how do you isolate a single cell for single cell proteomics??

see references on plasma proteomics

[evoldir]

Postdoc: MaxPlanck_Tuebingen.ComplexTraitGenomicsAndStemCells.Mouse

GENETIC MAPPING IN MOUSE INTERSPECIFIC HYBRIDS USING *IN VITRO* CROSSES (HybridMiX) Friedrich Miescher Laboratory, Max Planck Campus, Tbingen, Germany Two postdoctoral positions (both for 2 years in the first instance) are available in the Chan Lab at the Max Planck Institute in Tbingen as part of our HybridMiX team, which is supported by an 1.5M EUR European Research Council (ERC) grant on using "in vitro" mitotic recombination crosses to study species differences between mouse species. The key innovation in the HybridMiX project is the development of in vitro recombination (IVR) in tissue culture, specifically in F1 interspecific hybrid mouse ES cells for genetic mapping (see Lazzarano et al., PNAS, 2018). IVR allows us to create recombinant cell lines across species of effectively unlimited panel size, at low costs and within. We now aim to map the evolutionary divergence between mouse species at the tissue and cellular level by generating interspecific panels and obtaining their phenotypes via tissue engineering, organ-on-a-chip or droplet microfluidic single-cell methods. We're looking for highly motivated candidates (both wet and dry-lab) to contribute to the broader team effort in our HybridMiX project in tissue engineering and genetic mapping. The successful candidates should be about to earn, or have recently earned their PhD in the areas of genetics, molecular biology or regenerative medicine (wet-lab position); or statistical, functional or quantitative genomics (dry-lab computational position). Successful candidates should demonstrate their early career success in the form of a first author publication or preprint in prep. The ideal candidates should have the following qualifications. 1) Wet-bench Postdoc: You should demonstrate expertise in tissue culture techniques, especially in the area of differentiation or flow-based cultures. Alternatively you may be familiar with single-cell techniques and with performing functional genomics experiments such as RNAseq, ATACseq and ChIPseq. Together, we aim to use these approaches to dissect the genetic architecture of gene expression evolution in mouse tissue models. For this position, a background in genetic mapping or GWAS will be advantageous. 2) Data analysis Postdoc: You should have a strong background in analyzing genomic data and the proficiency to handle large datasets, (e.g. skills in Unix, R and scripting or programming languages). In our projects we routinely integrate information from diverse sources, including single-cell, linked-read, chromosome conformation capture, as well as image analysis to assist with our analyses of cellular and tissue-level phenotypes and genotypes. For both positions, a background in evolutionary biology will be helpful, but not a requirement. We are interested in candidates who are keen to apply and develop new genetic tools and technologies. You will have plenty of opportunity to develop independent research ideas within our in vitro cross framework. We are a multidisciplinary team that focuses on the systems biology of development and evolution in mice, combining population and functional genomics with molecular biology and tissue engineering techniques to investigate the evolution of complex genomes like the mouse. Our research group is funded by the ERC and the Max Planck Society and is located on the Max Planck Campus in Tbingen, Germany. The Max Planck Tbingen Campus is a highly innovative research hub with world-class genomics and machine learning expertise. Our sequencing core features the Illumina, PacBio and 10X Genomics platforms. English is the working language. All seminars and communications are in English. The position is available for an initial 2 years with the possibility of extension. Salary and benefits are according to the German public service pay scale (TVD Bund up to and including E13) and are commensurate with training and experience. The Max Planck Society seeks to increase the number of women in areas where they are underrepresented, and therefore explicitly encourages women to apply. The Max Planck Society is committed to employing more handicapped individuals and especially encourages them to apply. For more information please see: http://bit.ly/2JgtCoC Consideration of applications will begin on 1 Dec 2018. The projected start date is in early 2019 but can be negotiable. Please send your informal enquires or applications to Dr. Frank Chan at frank.chan@tue.mpg.de. Complete applications should include: 1. a statement of research interests and why you have applied for this position, 2. your CV, and 3. three reference contacts Publication: Lazzarano et al., Genetic mapping of species differences via in vitro crosses in mouse embryonic stem cells. PNAS, 2018. doi: 10.1073/pnas.1717474115 via Gmail

[biotechtimes]

NCBS Graduate Trainee Recruitment – Bioinformatics Vacancy

New Post has been published on https://biotechtimes.org/2020/11/09/ncbs-graduate-trainee-recruitment-bioinformatics-vacancy/

NCBS Graduate Trainee Recruitment – Bioinformatics Vacancy

NCBS Graduate Trainee Recruitment

NCBS Graduate Trainee Recruitment – Bioinformatics Vacancy. National Centre for Biological Sciences Bioinformatics job vacancies. NCBS Bioinformatics Jobs 2020. Interested candidates can check out the job details below:

Bioinformatics Vacancy

Job description:

This role is in the laboratory which performs basic cardiovascular and cerebrovascular studies. The selected candidate will closely work with the principal investigator and will be studying the role of vascular genes regulating artery remodeling in the mouse heart.

Research work involves bioinformatic analyses of single-cell RNA sequencing datasets relevant to the development of coronary arteries and cardiac regeneration. The candidate will develop a pipeline for analyses of single-cell RNA sequencing datasets and analyze different sequencing datasets. The candidate will work individually and collaboratively with other lab members and occasionally provide bioinformatics support to the lab members performing wet lab work. Additionally, the candidate will participate in lab discussions and present data in meetings.

Position Name: Graduate Trainee

Number of positions: 1

Contract term: The position will be for 1 year subject to a performance review after 3 months. At the end of the first year, there will be potential for extending the contract by one more year.

Minimum % of marks: 75%

Age limit: 30

Salary offered: 31000 + 24% HRA

Essential Qualification & Experience required:

MSc

Convergent with bioinformatics, statistics tools, resources and packages

Prior experience in New Generation Sequencing (NGS) data analyses (eg. WGS, RNA seq, ChipSeq)

Proficient in R programming language, and other scripting languages

Knowledge of Genomic databases

Research experience of a minimum of 2 years, preferably 3-4 years

Excellent communication (written and oral) skill

How to apply: Interested applicants are requested to apply with their CV and a statement of research interest (~300 words) pertinent to the position by November 30, 2020. Applications should be sent to soumyashree@ncbs.res.in as one pdf file. Please mention the advertisement number in the subject line. Incomplete applications will not be considered.

Shortlisted applicants will be invited for an online interview which may comprise multiple rounds to assess the candidate’s fit for the position.

View Notification

[biomedgrid]

Biomed Grid | Recent Advance in Biomedical Omics Data Analysis

Short Communication

Sequencing technology is dominant in the study of complex human genetic diseases. Identified risk genes and other biomarkers will make genetic counselling, risk assessment and avoidance, and disease diagnosis and treatment possible. Benefit from the discovered biomarkers, many diseases could be accurate diagnosed and prevented, as well as accurate treated. Nevertheless, the molecular mechanisms of many neuropsychiatric disorders are still unclear and there are no effective treatments for these neuropsychiatric disorders. The rapid development of whole genome sequencing technology, large amounts of genetic data are generated concerning larger cohorts with diverse neuropsychiatric disorders [1], making it possible to detect various genetic variants, i.e. SNVs, InDels, and SVs. Genetic research of these disorders are focused on genome-wide association analysis (GWAS), pedigree analysis, twin family studies, trio family studies, etc., Over the last decades, GWAS have identified several hundred loci for neuropsychiatric disorders successfully [2,3]. Whole exome/ genome sequencing have greatly facilitated the identification of risk de novo variants [4]. Besides, with the increasing amount of patient cohorts, more and more risk mutations have been discovered [5].

However, there is still a deep gap between the explaining the molecular mechanisms and thousands of risk gene locis identified in the past years using GWAS. For example, it has been reported that 142 risk mutation locis contribute to schizophrenia, while most of these locis do not contain any genes and it is not clear how they related to the disorder. Traditional single-dimensional genomic study are less useful in explaining the mechanisms of these disorders [6,7]. However, with the decreasing cost of sequencing technologies, large amounts of omics data become available using RNA-seq [8]. ChIp-seq [9]. Methyl-seq [10] Hi-C[11-12] and ATACseq [13-14] etc Whole exome/genome sequencing could generate the sequence information of genes. RNA-seq technology could be used for genotyping and identification of transcription factor binding sites, as well as generating gene expression data. ChIpseq (Chromatin immunoprecipitation followed by sequencing) could be used for genome-wide profiling of DNA-binding proteins, histone modifications or nucleosomes. Methyl-seq could be used for detecting and quantify DNA methylation. Hi-C (high throughput chromatin conformation capture) technology is a method to study the three-dimensional architecture of genomics and could be used to comprehensively detect chromatin interactions in the mammalian nucleus. And ATAC-Seq (assay for transposaseaccessible chromatin with high throughput sequencing) could be used for mapping chromatin accessibility genome-wide. With all these biotechnologies, we could detect mutations in gene sequence, gene regulation and epigenetic mechanisms, reactivities of methylated and nonmethylated cytosines, chromatin interactions, and variations in gene expressions under complex disease phenotypes.

Recently, the accumulation of multi-omics data and singlecell sequencing data have greatly promoted the development of machine learning algorithms, statistical learning methods, and deep learning methods. Integrative analysis of multi-omics data generated by various sequencing technologies is helpful for screening robustness biomarkers related to diseases. Diagnosis and treatment should be further personalized according to multidimensional information [15]. Nowadays, applications of machine learning and deep learning methods are becoming ubiquitous in biology and encompass not only risk gene identification, but also protein binding prediction, disease subtypes classification, and transcriptional regulatory networks characterization, etc. [16,17]. In the near future, these intelligent computational methods should be further used to multi-omics data integrated analysis.

Read More About this Article:https://biomedgrid.com/fulltext/volume3/recent-advance-in-biomedical-omics-data-analysis.000731.php

For more about: Journals on Biomedical Science :Biomed Grid

[healthcarebiz]

European NGS Service Providers Prepare to Leverage Growing Demand for Exome and RNA Sequencing

High-end providers with superior coverage, quality and turnaround will monopolise growth opportunities, finds Frost & Sullivan's Transformational Health team

LONDON, June 8, 2017 /PRNewswire/ -- The European next-generation sequencing (NGS) services market is undergoing transformation propelled by rapid technological innovations. Decreasing cost, launch of large-scale sequencing projects, and improved capacity are fuelling rapid growth. By 2023, the market will be worth $605.0 million, spearheaded by high-end providers with superior coverage, quality, and turnaround.

"Low-cost and quick turnaround have amplified NGS uptake as an alternative to traditional microarray, capillary electrophoresis (CE) and Sanger methods, propelling demand across industries such as human genetics, plant and animal biotech, agriculture, microbiome, food and drug safety, and forensics," noted Transformational Health Unmesh Lal, Program Manager Life Sciences. "To align with upcoming growth opportunities in research and clinical applications, NGS service companies are expanding service lines with specialised applications beyond pure sequencing. These include customised gene panels, Exome sequencing, ribonucleic acid (RNA) sequencing, chromatin immunoprecipitation sequencing (ChiPseq), and methylation sequencing (MethilSeq)."

European Next-generation Sequencing Services Market, Forecast to 2023, new research from Frost & Sullivan's Life Sciences Growth Partnership Service program, analyses the NGS services market potential, providing insights on key trends, drivers and their implications. NGS services are primarily driven by research, followed by applied market segments. The study covers NGS conducted with next-generation platforms, such as sequencing-by-synthesis, sequencing-by-ligation, and single-molecule sequencing.

Click here (http://frost.ly/1ns) to learn more about the European Next-generation Sequencing Services Market and to talk to us.

Several trends and developments bolster the European NGS services market:

Government-backed, large-scale projects like flagship 100,000 Genomes and France Genomic Medicine 2025 will bring genomics to the forefront and make NGS a routine process.

Strategic alliances and collaborations are increasing to enhance NGS bioinformatics capabilities and develop unique service lines catering to clinical sequencing and genetic testing.

NGS companies are actively expanding installed base to become the preferred private partners.

Launch of high-throughput sequencers are setting new service standards with focus on superior coverage and accuracy. Global leaders BGI, Illumina, Macrogen, and GENEWIZ are expanding presence in the region.

Mid-range, high-throughput sequencers provide excellent opportunity for local service providers to capitalise on medium-scale clinical application needs. Regional participants like CeGaT, IntegraGen, Source Bioscience, QIAGEN, and GATC Biotech lead the market with high-end, superior-quality services. Other companies to watch include Oxford Gene Technology, LGC Genomics, NewGene, Lifesequencing, Genomix4life, Microsynth, and DNA Vision.

Game-changing companies are concentrating on novel Exome sequencing and RNA sequencing applications in niche market segments.

"Stringent reimbursement policies guided by cost-containment models, a fragmented NGS value chain, and political and economic factors are, however, creating market volatility in the short term," noted Lal. "Further, advancement and consumerisation of portable, real-time sequencers may reduce dependence on service providers for small-scale project needs."

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Contact us: Start the discussion

European Next-generation Sequencing Services Market, Forecast to 2023 MCE8-52

Contact: Jana Schöneborn Corporate Communications -- Europe P: +49 (0)69 77033 43 E: jana.schoeneborn@frost.com

http://ww2.frost.com twitter: @FS_Healthcare LinkedIn: Transform Health

  Read this news on PR Newswire Asia website: European NGS Service Providers Prepare to Leverage Growing Demand for Exome and RNA Sequencing

[jobrxiv]

Postdoctoral Fellow University of Texas MD Anderson Cancer Center The Ishak laboratory at MD Anderson Cancer Center is seeking candidates for a Postdoctoral Fellowship. See the full job description on jobRxiv: https://jobrxiv.org/job/university-of-texas-md-anderson-cancer-center-27778-postdoctoral-fellow/?feed_id=55361 #ScienceJobs #hiring #research #ViralMimicry, #DNArepetitiveElements, #epigenetics, #cancer, #premalignancy, #p53, #OvarianCancer, #MolecularCarcinogenesis, #MolecularBiology, #CRISPR, #ChIPseq, #immunology Houston, Texas #UnitedStatesUS #PostdoctoralFellow

[biodiscovery-group]

Join us in #Dubai for 2 Hands-on Workshops and get free Desert Safari Tour. THE ATTRACTIONS ARE - Entertainment Shows- Belly Dance, Tenura Dance, Live Fire Show & Halla Dance - Dune Bashing- Experience Off-Drive - Camel Ride- enjoy A Short Ride At Humens Friendly Camels Hump - Surf Sand Board, Capture Sun Set, Free Heena Tattoos B.B.Q Buffet Dinner Register Now Drug Discovery Workshop- NGS & Genome Editing Workshop- https://www.explara.com/e/drug-discovery-dubai https://in.explara.com/e/nextgenerationsequencing-crispr-dubai All upcoming events- https://www.biodiscoverygroup.com/workshops #ngs_course_in_dubai #NextGenerationSequencingDataAnalysis #NextGenerationSequencing #NGS #bioinfo #itsdifferentbybiodiscovery #bdglifesciences #biodiscoverygroup #biotechnology #biotech #DNAseq #RNASeq #ChipSeq #denovo_assembly #genetics #dbSRA #Genomics #computationalgenomics #biotechnology_dubai #UAE #AbuDhabi #Sharjah #MiddleEast #Gulf #GCC #traveldubai #dubaitravel #dubainightlife #dubaidiaries #travelUAE #travelmiddleast #DNA #RNA #DNAsequencing #moleculardocking #admet #smallmolecule #drugtarget #pharmaceuticalchemistry https://www.instagram.com/p/B1c2Byjh3RI/?igshid=3wjrllhc5mlz

[biodiscovery-group]

#DUBAI, UAE | 2-day #Technical Hands-on #Bioinformatics #Workshop in Next Generation Sequencing Data Analysis on 14-15 October 2019 at Executive Lounge, Business Centre, #SheikhZayedRoad, Dubai #UnitedArabEmirates. Event webpage- https://in.explara.com/e/nextgenerationsequencing-dubai All upcoming #training, workshop & events- https://www.biodiscoverygroup.com/workshops #ngs_course_in_dubai #NextGenerationSequencingDataAnalysis #NextGenerationSequencing #NGS #bioinfo #itsdifferentbybiodiscovery #bdglifesciences #biodiscoverygroup #biotechnology #biotech #DNAseq #RNASeq #ChipSeq #denovo_assembly #genetics #dbSRA #Genomics #computationalgenomics #biotechnology_dubai #UAE #AbuDhabi #Sharjah #MiddleEast #Gulf #GCC #traveldubai #dubaitravel #dubainightlife #dubaidiaries #travelUAE #travelmiddleast #DNA #RNA #sequencingbyligation https://www.instagram.com/p/B1T9tnVhGpk/?igshid=10d5m4kb5myqz

[jobrxiv]

Postdoct in epigenetics of neural developmental and disorders Children's Hospital of Philadelphia Application Deadline: 2022-11-15 The Akizu lab seeks candidates for a postdoctoral position in epigenetic mechanisms of neural developmental and disorders. The applicant must have a recent PhD in relevant fields, research experience in epigenomic (i.e. ChIPseq, Cut&Run, ATACseq, Hi-C…) OR human pluripotent stem cell culturing and organoid differentiation methods, and at least one first author publication in an impactful scientific journal. The ideal candidate must be highly motivated and creative with strong ability to design and carry out experiments with a high level of independence. The successful candidate will work full time in one of our recently funded projects while also collaborating with other lab members and investigators in our institution. As part of career development training the candidate will be encouraged to apply for fellowships, present posters and talks in scientifically relevant conferences, and contribute to manuscript writing and submission. Our lab studies genetic and epigenetic mechanis... See the full job description on jobRxiv: https://jobrxiv.org/job/childrens-hospital-of-philadelphia-27778-postdoctoral-in-epigenetics-of-neural-developmental-and-disorders/?feed_id=25045 #ScienceJobs #hiring #research

[jobrxiv]

Postdoct in epigenetics of neural developmental and disorders Children's Hospital of Philadelphia Application Deadline: 2022-11-15 The Akizu lab seeks candidates for a postdoctoral position in epigenetic mechanisms of neural developmental and disorders. The applicant must have a recent PhD in relevant fields, research experience in epigenomic (i.e. ChIPseq, Cut&Run, ATACseq, Hi-C…) OR human pluripotent stem cell culturing and organoid differentiation methods, and at least one first author publication in an impactful scientific journal.   The ideal candidate must be highly motivated and creative with strong ability to design and carry out experiments with a high level of independence. The successful candidate will work full time in one of our recently funded projects while also collaborating with other lab members and investigators in our institution. As part of career development training the candidate will be encouraged to apply for fellowships, present posters and talks in scientifically relevant conferences, and contribute to manuscript writing and submission.   Our lab studies genetic and epi... See the full job description on jobRxiv: https://jobrxiv.org/job/childrens-hospital-of-philadelphia-27778-postdoctoral-in-epigenetics-of-neural-developmental-and-disorders/?feed_id=22590 #ScienceJobs #hiring #research

[evoldir]

Fwd: Graduate position: UMainz.EvolutionaryBiology

Begin forwarded message: > From: evoldir@web.rhpcs.mcmaster.ca > Subject: Graduate position: UMainz.EvolutionaryBiology > Date: 7 December 2021 at 05:42:28 GMT > To: rdmpage@gmail.com > > > > PhD position in Evolutionary Biology > > Role of gene regulation in the social control > of queen behavioral specialization in ants > > Registration deadline: > 20 January 2022 > Application deadline: > 27 January 2022 > > The Libbrecht group at the Johannes Gutenberg University of Mainz > (Germany) is offering a 3-year PhD position (DFG, fully funded with > possibility of extension, 65% TVL E13) to study the role of gene > regulation in the social control of queen behavioral specialization in > ants. The PhD student will be supervised by Romain Libbrecht (JGU Mainz) > in collaboration with Joe Colgan (JGU Mainz), Ren� Ketting (IMB Mainz) > and Franjo Weissing (University of Groningen), and will be integrated > in the GenEvo research training program (https://ift.tt/30Q4mn1). > > Division of labor between specialized castes is central to the functioning > and evolution of insect societies. > > Queens monopolize reproduction, while workers perform all the tasks > necessary to maintain the colony. Queens are typically seen as egg > production units, to the point where their function in insect societies > has been compared to that of the germline in multicellular organisms. Some > of our recent work has challenged this longstanding view by revealing > unexpected flexibility in queens of the black garden ant Lasius niger. We > have shown that the presence of workers inhibits brood care behavior in > founding queens. Moreover, we found that removing workers from established > colonies caused old queens to revert to expressing brood care. These > results indicate that the presence of workers not only initiates, but also > maintains the behavioral specialization of queens that can live up to 30 > years. As a means to understand the molecular basis of queen behavioral > specialization, we have also performed brain RNAseq to identify genes > that differ in expression between queens with and without workers. In > this project, we will ask the question: What are the gene regulatory > mechanisms that regulate the gene expression changes underlying the > social control of queen brood care behavior?  The project will include > empirical and theoretical components. The empirical investigations will > involve the collection and experimental manipulations of ant colonies, > extensive behavioral analyses, RNAi knockdown of candidate genes, > molecular biology techniques, sequencing technologies (e.g., RNAseq, WGBS, > ChIPseq) and associated bioinformatics analyses. The theoretical aspects > will be developed in collaboration with Franjo Weissing, including via > a research stay in his group at the University of Groningen. > > We are looking for a highly motivated student with a Master degree > (or equivalent) in biology, good English skills, and a keen interest > in evolutionary biology. Previous experience with social insects, > molecular biology, statistics and bioinformatics is advantageous, but > not required. The successful applicant will join an international, > interactive, dynamic and English-speaking scientific environment in > a brand new building with access to state-of-the-art, newly equipped > laboratories and climate-controlled rooms. The JGU of Mainz hosts many > excellent scientific institutions, and Mainz is a historic city located > on the Rhine River with a large student population and a rich social > and cultural life. > > Interested candidates should register to the IPP > (https://ift.tt/31Cmdhh) before 20 January 2022 and complete > their application before 27 January 2022. Informal enquiries should be > sent to Dr. Romain Libbrecht (romain.libbrecht@uni-mainz.de). > > The starting date for the position is 1 July 2022. The Johannes Gutenberg > University of Mainz is interested in increasing the number of women in > science. Applications from women are therefore strongly encouraged. In > addition, qualified candidates with disabilities will be preferred. > > > > Dr. Romain Libbrecht > > Assistant Professor / Junior Group Leader > > Institute of Organismic and Molecular Evolution > Johannes Gutenberg University > > Mainz, Germany > > +49 6131 3927852 > > https://ift.tt/3ouAkhk > > "Libbrecht, Dr. Romain" > via IFTTT

[biodiscovery-group]

#DUBAI, #UAE | 2-day #Technical Hands-on #Bioinformatics #Workshop on Next Generation Sequencing Data Analysis on 14-15 October 2019 at Executive Lounge, Business Centre, #SheikhZayedRoad, Dubai #UnitedArabEmirates. Event webpage- https://in.explara.com/e/nextgenerationsequencing-crispr-dubai All upcoming #training, workshop & events- https://www.biodiscoverygroup.com/workshops Feedback Videos- https://www.youtube.com/Biodiscoverygroup #ngs_course_in_dubai #NextGenerationSequencingDataAnalysis #NextGenerationSequencing #NGS #bioinfo #itsdifferentbybiodiscovery #bdglifesciences #biodiscoverygroup #biotechnology #biotech #DNAseq #RNASeq #ChipSeq #denovo_assembly #genetics #dbSRA #Genomics #computationalgenomics #biotechnology_dubai #AbuDhabi #Sharjah #MiddleEast #Gulf #GCC #traveldubai #dubaitravel #dubainightlife #dubaidiaries #travelUAE #travelmiddleast #DNA #RNA #sequencing https://www.instagram.com/p/B15d7eSF1hd/?igshid=1ul04ydg1mqjr